![]() Abiogen Pharma Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases. | ![]() Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. | ![]() Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. | |
Founding Date | Founding Date 1997 | Founding Date 1988 | Founding Date 1992 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Pisa, IT HQ | Locations Leiden, NL HQ Leiden, NL | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more |
Employees | Employees 351 | Employees 404 | Employees 10,6006% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 590.3 m | Valuation ($) 40.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) $6.1b (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods $41.6m (FY, 2025) | Cost of goods $553.5m (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit $341m (FY, 2025) | Gross profit $5.5b (FY, 2020) |
Net income | Net income N/A | Net income $2.5m (FY, 2025) | Net income $603.4m (FY, 2020) |

Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View company
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View company